MannKind Corporation (MNKD) had a good day on the market for Tuesday December 10 as shares jumped 5.74% to close at $1.29. About 1.67 million shares traded hands on 3,337 trades for the day, compared with an average daily volume of n/a shares out of a total float of 206.41 million. After opening the trading day at $1.23, shares of MannKind Corporation stayed within a range of $1.29 to $1.21.
With today’s gains, MannKind Corporation now has a market cap of $266.27 million. Shares of MannKind Corporation have been trading within a range of $2.34 and $0.94 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
MannKind Corp is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of therapeutic products and solutions for the patients with the diseases such as diabetes. Its products and technologies include Afrezza, Dry powder formulation, Inhalation profiling, Oral inhalers and others. The company has following products in the pipeline: Epinephrine technosphere, Treprostinil technosphere, and Palonosetron technosphere.
MannKind Corporation is based out of Westlake Village, CA and has some 225 employees. Its CEO is Michael E. Castagna.
MannKind Corporation is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
